Menu
Vision & Mission
Our Vision
We envision Skope to impact the diagnostic value of every MRI examination in the world.
Our Mission
We push the boundaries of MR to create insights for researchers – "Towards a world without patients."
Our Story
Skope Magnetic Resonance Technologies was founded in 2011 as a spin-off from ETH Zurich and University of Zurich, Switzerland. End of 2019 Skope was acquired by Canon Medical Systems Corporation.
True to its name – inspired by the Greek word skopein, ‘to observe, to see’ – Skope is focusing on bringing accuracy and detail to magnetic resonance imaging (MRI) by combining sensor technology with advanced MR signal processing and image reconstruction.
- 2025: Launched NYOXTM - One Platform for Field Monitoring
- 2024: Skope moved to new offices at Thurgauerstrasse 39 in Zurich
- 2023: Launched NeuroCamTM 7T and skope-dm
- 2021: Launched Clip-on Camera Cranberry Edition
- 2019: Skope was acquired by Canon Medical Systems Corporation
- 2018: Launched NeuroCamTM 3T
- 2018: First International Skope User Meeting
- 2017: Received Innosuisse funding to develop skope-i, together with ETH Zurich
- 2013: Delivered the first Skope AQ System. User - University of Leiden, the Netherlands
Team
